Three pilot studies, one investigator, roughly 30 subjects, and no randomized controlled trial
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
Or maybe not even among the best
This peptide chain has 15 different amino acids derived from human gastric protein
One option gaining attention in wellness and medical spa settings is BPC-157 for tendon healing
Other Hair Treatments Lets be honest: most hair care brands rely on buzzwords, filler ingredients, and peptides in barely-there amountsoften with impurities they never disclose
